Crossmark

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?

Crossref DOI link: https://doi.org/10.1186/s12931-018-0813-0

Published Online: 2018-06-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matucci, Andrea

Vultaggio, Alessandra

Maggi, Enrico

Kasujee, Ismail
Funding

Funding for this research was provided by:

Novartis Pharma AG
License Information

Text and Data Mining valid from 2018-06-08
More Information

Article History

Received: 22 December 2017

Accepted: 14 May 2018

First Online: 8 June 2018

Ethics approval and consent to participate

: Not applicable.

: AM and AV have received payment for lectures from Novartis, GlaxoSmithKline, Teva, AstraZeneca and have consultant arrangements with Novartis, GlaxoSmithKline, Teva, AstraZeneca. EM has received research support from Novartis, and has consultant arrangements with Novartis, AstraZeneca; Teva, Sanofi. AP, FS, XJ and IK are full-time employees of Novartis.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.